SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001069530-23-000011
Filing Date
2023-03-08
Accepted
2023-03-08 16:07:41
Documents
1
Period of Report
2023-03-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4.html 4  
1 PRIMARY DOCUMENT certent-form4.xml 4 5356
  Complete submission text file 0001069530-23-000011.txt   6849
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 MARGALITA DRIVE SAN RAFAEL CA 94901
Business Address
Barry Richard (Reporting) CIK: 0001562371 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29959 | Film No.: 23716202